Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Disorders of Hemostasis01:24

Disorders of Hemostasis

1.9K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

1.1K
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.1K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

193
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
193
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

4.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

334
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
334

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Validation of a pan-ELastography Machine-learning (ELM) score to predict clinically significant portal hypertension in compensated advanced chronic liver disease.

Journal of hepatology·2026
Same author

Employment and work absenteeism in individuals living with a vascular liver disease: a European multicenter study.

Clinics and research in hepatology and gastroenterology·2026
Same author

Hepatic Venous Pressure Gradient, Noninvasive Tests, and Prognosis Across the Subtypes of Advanced Steatotic Liver Disease.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF.

Hepatology international·2026
Same author

A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF.

Hepatology (Baltimore, Md.)·2026
Same author

A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF.

Annals of hepatology·2026

相关实验视频

Updated: Jan 7, 2026

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies
09:51

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies

Published on: January 27, 2023

2.1K

[小肝血管疾病] 小肝血管疾病

Lucile Moga1, Pierre-Emmanuel Rautou1

  • 1Service d'hépatologie, AP-HP, hôpital Beaujon, DMU Digest, centre de référence des maladies vasculaires du foie, Filfoie, ERN Rare-Liver, Clichy, et Université Paris Cité, Inserm, centre de recherche sur l'inflammation, UMR 1149, Paris, France.

La Revue du praticien
|December 30, 2025
PubMed
概括
此摘要是机器生成的。

肝脏小血管疾病,如波尔托鼻状血管疾病 (PSVD),导致门口高血压没有肝硬化. 诊断依赖于肝脏活检,管理层反映肝硬化治疗.

关键词:
血管病变是一种血管病变.肝病是一种肝病.

更多相关视频

Multiphoton Microscopic Observation of Vessels in Mouse Liver Tissue
06:33

Multiphoton Microscopic Observation of Vessels in Mouse Liver Tissue

Published on: May 17, 2021

4.3K
A Standardized Method for the Analysis of Liver Sinusoidal Endothelial Cells and Their Fenestrations by Scanning Electron Microscopy
08:38

A Standardized Method for the Analysis of Liver Sinusoidal Endothelial Cells and Their Fenestrations by Scanning Electron Microscopy

Published on: April 30, 2015

15.3K

相关实验视频

Last Updated: Jan 7, 2026

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies
09:51

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies

Published on: January 27, 2023

2.1K
Multiphoton Microscopic Observation of Vessels in Mouse Liver Tissue
06:33

Multiphoton Microscopic Observation of Vessels in Mouse Liver Tissue

Published on: May 17, 2021

4.3K
A Standardized Method for the Analysis of Liver Sinusoidal Endothelial Cells and Their Fenestrations by Scanning Electron Microscopy
08:38

A Standardized Method for the Analysis of Liver Sinusoidal Endothelial Cells and Their Fenestrations by Scanning Electron Microscopy

Published on: April 30, 2015

15.3K

科学领域:

  • 肝病学 肝病学是一种肝病学.
  • 血管医学 血管医学
  • 罕见疾病 罕见疾病

背景情况:

  • 小肝血管疾病包括影响肝血管系统的罕见疾病.
  • 波尔托鼻状血管疾病 (PSVD) 是最常见的,其特征是没有肝硬化的门口高血压.
  • 病情通常与肝外疾病 (免疫,血液学,有毒) 有关.

研究的目的:

  • 要突出PSVD的诊断标准和临床意义.
  • 强调在特定的临床场景中考虑PSVD的重要性.
  • 概述PSVD的管理原则.

主要方法:

  • 通过肝脏活检确认诊断.
  • 每六个月一次使用成像检查门静脉血栓的查至关重要.
  • 临床表现和相关疾病指导诊断.

主要成果:

  • PSVD呈现为门高血压和保存的肝功能或低度.
  • 腹出血和门静脉血栓是关键的并发症.
  • 肝衰竭是PSVD的罕见结果.

结论:

  • 在无法解释的门高血压中考虑PSVD,特别是在正常的肝功能/硬度或相关的肝外疾病中.
  • 早期诊断和监测诸如门静脉血栓症等并发症至关重要.
  • 对于PSVD的管理策略与肝硬化病的管理策略相似.